Male Gluteoplasty Lecture
Myomodulation converts a transient chemical input into a controlled mechanical response through the interaction of directional forces within an anisotropic and viscoelastic muscular system.
The muscle acts as a transfer function: chemical signaling is translated into vector–tensor coupling, three-dimensional tissue redistribution and the functional outputs of myoplasty, myopexy and myotension.
Navigate through the complete mechanistic framework of Myomodulation, from chemical input and tissue interaction to biomechanical response, experimental evidence and clinical expression.
Myomodulation begins with a transient chemical input and culminates in a controlled mechanical response. The injected formulation does not act as a volumizing filler or permanent implant. Instead, it initiates local tissue interactions that are translated by the muscular system into directional changes in tone, geometry and three-dimensional tissue organization.
A stereochemically controlled formulation is delivered in the subcutaneous plane, producing localized physicochemical interaction without creating a permanent volumizing depot.
Muscle architecture, fiber orientation, resting tone, anisotropy and viscoelastic behavior determine how the transient chemical input is converted into a spatially organized mechanical response.
Directional mechanical outputs redistribute projection, tissue tension and local geometry through vector–tensor coupling without requiring persistent injected material.
Three-dimensional reshaping of muscle-related geometry and projection.
Controlled spatial repositioning and translation of tissue projection.
Modulation of resting tension while functional contractile activity is preserved.
The muscular system does not behave as a passive target. It transforms a transient chemical input into a directionally organized mechanical response. The resulting output depends on local anatomy, fiber orientation, resting tone, anisotropy and viscoelastic behavior.
Local physicochemical interaction initiated after controlled subcutaneous administration.
An active, anisotropic and viscoelastic biological system that converts chemical signaling into mechanical behavior.
Directionally organized deformation, redistribution of projection and modulation of tissue tension.
Local geometry determines how mechanical loading is distributed through the treated muscular region.
Directional organization of muscle fibers contributes to an anisotropic response rather than uniform deformation.
Baseline muscular tension influences the mechanical state from which myotension and reshaping develop.
Tissue response varies with direction. The same mechanical input does not generate identical deformation along every axis.
The muscular response combines immediate deformation with a time-dependent biological and mechanical adaptation.
In the Myomodulation model, the vector defines a single directional axis perpendicular to the local muscular plane. It establishes the normal deformation direction and must not be confused with tangential or in-plane tissue displacement.
The vector is unidirectional. It defines a local axis of mechanical action rather than a multidirectional field.
The vector establishes the local orthogonal axis along which projection and normal deformation can be expressed.
The vector is oriented normal to the local muscular surface. Its defining property is orthogonality.
It establishes the directional axis on which local three-dimensional deformation is organized.
The vector does not describe tangential transfer across the muscular plane. That in-plane organization belongs to the tensor field.
In the Myomodulation model, the tensor organizes directional action within the local muscular plane. Unlike the vector, it does not define a single perpendicular axis. It coordinates in-plane tissue transfer and contributes to the spatial redistribution of shape, tension and projection.
The tensor acts within the local muscular plane. Its role is to organize directional relationships between mapped points rather than define one single orthogonal axis.
The tensor coordinates tangential tissue displacement between mapped points and organizes the in-plane component of the three-dimensional mechanical response.
Tensor action is tangential to the local muscular surface and remains organized within that plane.
It represents a field of directional relationships rather than a single one-way action.
Its functional role is to organize tangential redistribution across the mapped tissue grid.
Skeletal muscle behaves as an active, anisotropic and viscoelastic biological material. Within the treatment grid, each local cell represents a deformable tissue unit whose mechanical response depends on direction, local architecture, resting tone and time-dependent tissue behavior.
Before loading, the local tissue unit has its own geometry, fiber orientation, resting tone and baseline mechanical state.
Normal and in-plane directional components act on a biological material whose deformation is neither uniform nor instantaneous.
The local cell changes shape according to directional loading and material properties, producing a three-dimensional strain response without requiring added material volume.
Muscle does not respond identically along every axis. Fiber orientation, fascial organization and local architecture modify how an applied load is transmitted and how each grid cell deforms.
The mechanical response combines an immediate deformational component with time-dependent adaptation. Tissue behavior therefore depends not only on load magnitude and direction, but also on time.
Three-dimensional reshaping emerges from the coupling of two distinct geometric components: a vector acting normal to the muscular plane and an in-plane directional tensor field. Their interaction organizes local deformation and tissue redistribution within an anisotropic and viscoelastic biological system.
Defines the local deformation axis normal to the muscular plane.
Organizes directional relationships and tangential tissue transfer within the muscular plane.
The coupled response modifies local geometry by redistributing existing tissue volume between spatial dimensions. Length, width and projection may increase, decrease or remain relatively stable according to the intended three-dimensional architecture, while overall material volume is preserved.
Three-dimensional modification of muscular geometry and projection.
Spatial translation and controlled repositioning of tissue projection.
Modulation of resting muscular tension while contractile activity is preserved.
Histologic and experimental observations provide biological support for a transient local tissue response following Myomodulation. Human tolerance observations and preclinical histology must, however, be interpreted separately and within the limits of their respective experimental models.
Early human histologic observations support preserved tissue architecture and local tolerance in the examined material.
Experimental tissue sections have shown localized vacuolization after exposure, followed in subsequent observations by structural restitution.
Histologic findings are compatible with a spatially localized tissue interaction rather than a persistent volumizing depot.
Vacuolization followed by restitution supports the concept of a reversible or transient microstructural event in the experimental tissue model.
The available human observations are consistent with tissue tolerance and preserved structural integrity in the examined samples.
Additional microscopic material and detailed histopathological observations are available in the dedicated histology section.
Molecular persistence and clinical duration are not equivalent. The components involved in the initial physicochemical interaction are cleared on substantially shorter timescales than the mechanical response observed clinically.
Hours to weeks
May persist for months
Controlled subcutaneous administration initiates the local physicochemical interaction that precedes the mechanical response.
According to the available formulation data, the aromatic acid component undergoes near-complete elimination within approximately twenty-four hours.
The arachidonic-acid-containing lipid carrier follows a longer clearance timescale, extending to approximately three weeks.
Clinical reshaping, repositioning and tension modulation may remain observable for months, despite clearance of the initially administered molecular components.
The persistence of the clinical effect should therefore not be interpreted as persistence of the injected preparation within the tissue.
The administered preparation provides an initial local physicochemical input rather than a permanent structural implant.
The muscular system converts that input through its architecture, resting tone, anisotropy and viscoelastic properties.
The resulting response involves spatial redistribution and modification of tissue geometry rather than persistence of injected material.
The mechanically reorganized state may remain clinically observable after the initial molecular components have been cleared.
The persistence and magnitude of the clinical response can vary according to the treated anatomy, local muscular architecture, baseline tissue characteristics, functional loading and treatment strategy.
The coupled mechanical response can be expressed clinically through three complementary outputs: three-dimensional reshaping, spatial repositioning and modulation of resting muscular tension. Their relative contribution depends on anatomy, treatment geometry and the intended aesthetic or functional objective.
Myoplasty describes controlled modification of muscle-related three-dimensional geometry. Existing tissue volume is redistributed to modify contour, projection and local shape without requiring volumetric augmentation.
Myopexy describes directional repositioning of muscle-related projection and tissue geometry. The point of maximal projection can be translated within the treated architecture according to the desired three-dimensional result.
Myotension describes modulation of resting muscular tension while functional contractile activity is preserved. The intended effect is not paralysis, but modification of the baseline mechanical state.
These outputs are not mutually exclusive. A single treatment strategy may combine reshaping, repositioning and tension modulation in different proportions according to the local anatomy and target geometry.
Myomodulation is based on redistribution of existing tissue geometry. Length, width and projection can each increase, decrease or remain relatively stable depending on the desired morphology, while overall material volume remains preserved.
May decrease, increase or remain relatively stable.
May increase, decrease or remain unchanged according to the target contour.
Redistribution determines the location and magnitude of projection.
Preserved within the isovolumetric reshaping model.
There is no single predetermined shape. The directional strategy is adapted to the morphology to be preserved, reduced, expanded, translated or redistributed.
Width may remain relatively stable when the objective is to preserve the existing lateral architecture.
Width may be increased when lateral expansion or reduction of an external concavity is part of the intended morphology.
Width may also be reduced when a narrower architecture is the intended mechanical and aesthetic target.
Myomodulation can be represented as a multistage mechanistic framework in which a transient chemical input is translated by active muscular tissue into a directionally organized mechanical response. The final clinical expression emerges from tissue-specific vector–tensor coupling, anisotropic and viscoelastic behavior, and three-dimensional redistribution of existing tissue geometry.
Controlled subcutaneous administration initiates a localized physicochemical interaction. The injected preparation acts as a transient input and is not intended to function as a permanent volumizing depot.
Skeletal muscle behaves as an active, anisotropic and viscoelastic biological material. Local architecture, fiber orientation, resting tone and time-dependent material behavior determine how the transient input is translated into mechanical response.
Defines the conceptual deformation axis normal to the local muscular plane.
vectorial mechanical response
Organizes directional relationships and redistribution within the local muscular plane.
Local tissue units do not deform uniformly. Directional loading is filtered by muscle architecture, anisotropy, baseline tension and viscoelastic behavior, creating a spatially and temporally organized three-dimensional response.
Conceptual mechanistic representation — not a patient-specific quantitative material model.
The resulting mechanical response redistributes existing tissue geometry rather than adding volume. Length, width and projection are target-dependent variables and may increase, decrease or remain relatively stable according to the intended architecture.
Modification of muscle-related geometry, contour and projection.
Directional translation of tissue projection within the treated architecture.
Modulation of resting muscular tension while contractile activity remains preserved.
The molecular components are eliminated on timescales considerably shorter than the potential duration of the clinical response.
Persistence of the mechanical result does not require persistence of the injected material within the tissue.
Experimental observations at the neuromuscular and electrophysiologic levels provide additional support for the functional interpretation of Myomodulation. These findings should be considered as complementary evidence rather than as isolated proof of the complete mechanistic model.
Synaptophysin is associated with presynaptic vesicular structures. Changes observed in experimental material may indicate a local neuromuscular response within the treated environment, but they should not be interpreted in isolation as evidence of neuromuscular blockade or paralysis.
The electrophysiologic observations are relevant because the clinical concept of Myomodulation is not based on suppression of muscle activity. Functional contractility is intended to remain preserved while resting mechanical behavior is modulated.
The experimental framework is consistent with a distinction between modification of resting muscular behavior and pharmacologic neuromuscular blockade.
Experimental physiology supports an increase or modulation of the resting mechanical state of the treated muscle.
Muscle activity remains functionally preserved rather than being intentionally suppressed.
The intended effect differs fundamentally from paralytic neuromodulation.
Experimental tissue observations and visible clinical outcomes belong to different levels of evidence. The former can inform mechanistic interpretation; the latter illustrate the clinical expression of the resulting tissue response.
The image is compatible with a model in which localized tissue interaction modifies the mechanical behavior of the treated region, with visible consequences for contour, firmness and surface architecture.
The visible result can be interpreted as the clinical expression of altered local tissue tension, support and three-dimensional contour rather than as simple volumetric filling.
Histologic, microscopic or physiologic findings describe what is observed within a specific experimental setting.
These findings can support a mechanistic hypothesis involving changes in local tissue behavior, architecture and mechanical response.
Visible changes in contour, firmness, projection or tension represent the clinical phenotype of the resulting mechanical response.
Historical clinical material also includes observations in the periorbital region. Such images may illustrate visible changes in local appearance, but they should not be used to define the central muscular mechanism of Myomodulation.
Key scientific questions about Myomodulation, its mechanical framework, tissue response, duration of action and clinical interpretation.
Myomodulation is represented as a multistage mechanistic framework: a transient local chemical input is translated by active muscular tissue into a directionally organized mechanical response.
Muscle functions as an anisotropic and viscoelastic transfer system. Vector–tensor coupling then contributes to three-dimensional redistribution of existing tissue geometry.
No. The model is isovolumetric rather than volumizing. The objective is redistribution of existing tissue geometry, not creation of volume through a persistent filler depot.
Length, width and projection may increase, decrease or remain relatively stable according to the intended three-dimensional architecture, while overall tissue volume is preserved.
The vector V⊥ defines the normal-to-plane deformation axis. It is conceptually oriented perpendicular to the local muscular plane.
The tensor T∥ organizes directional relationships within the muscular plane and contributes to in-plane redistribution.
The proposed functional model is not based on paralysis or intentional neuromuscular blockade.
Experimental physiology is compatible with modulation of resting muscular tension while contractile activity remains preserved.
These three outputs can coexist within the same treatment strategy in different proportions according to anatomy and target morphology.
Molecular presence and clinical duration are different timescales. The aromatic acid component is cleared rapidly, while the lipid carrier follows a longer but still limited clearance period.
The clinical mechanical response may nevertheless remain observable for months because the result is interpreted as a reorganized mechanical state rather than persistence of injected material.
Histologic observations support the existence of localized tissue interaction and transient microstructural change within the examined experimental material.
Preclinical vacuolization followed by restitution is compatible with a transient response, while early human material supports tissue tolerance in the examined samples.
No. Clinical photography demonstrates visible outcome but does not, by itself, establish the molecular or biomechanical causal pathway.
Experimental observations, mechanistic interpretation and clinical expression represent different levels of evidence and should remain explicitly separated.
No. The model is target-dependent rather than shape-prescriptive.
Length, width and projection can be modified differently according to the morphology being sought. The mechanical strategy therefore depends on local anatomy and the intended three-dimensional architecture.
The current framework should be understood as an integrated conceptual mechanistic model.
Histologic, physiologic, electrophysiologic and clinical observations provide support for individual components, but the complete model should not be interpreted as a fully validated quantitative constitutive law.
The mechanisms described on this page form part of a broader scientific framework integrating chemistry, tissue interaction, biomechanics, histology and clinical mechanical expression.
Explore formulation, stereochemistry, controlled tissue interaction and molecular clearance.
Review microscopic observations, tissue tolerance and experimental microstructural findings.
Continue through the complete Myomodulation scientific architecture and related research topics.
The authors studied the alteration of the gait and the tissue reaction of the muscle which got an Myomodulation injection.
We chose to apply Myomodulation into the pre tibial muscle of rats and study the histological alterations.
The choice of the pre tibial muscle of rats was made because of similarity as weight with the depressor muscle of the corner of the mouth in humans.
Objective : Study the biological phenomenon caused by the Myomodulation injection into the pre tibial muscle of the Wister Rat and evaluate the alterations in its gait and the histopathological alteration in the applied muscle.
Read More about the Main Authors
Experimentators : R.Mené,M.Kim,A.Tenenbaum,M.Tiziani
N= 29 Wistar rats
Weight mean : 421g
Origin of animals : Biotério Central of Campus of Ribeirão Preto of São Paulo University
Maintenance : Experimental Pathology Lab of Pathology Department on Medicine School of Ribeirão Preto – USP
Animals keeping : polypropylen boxes
Animals food : basic diet of lab and water
Light conditions : natural light/dark cycles under controlled basic conditions
Experimentators : A.Tenenbaum,R.Mené,M.Kim,M.Tiziani
Conventional Microscopy
The mice were euthanized in CO2 chambers.
-hematoxilin-eosin
-Masson´s trichrome
-and red picro-sirius.
6 boxes
The mice of boxes 2 to 5 received 0,1 ml of Myomodulation Original Main Product on the same muscle as control group.
Box 6 was constituted of 4 rats, and each one received 0,5 ml of Myomodulation original main product injected on the subcutaneous layer.
All the animals were submitted to walking evaluation before and after their respective injections.
Animals are sacrified after 10 days-1 month- 3 months-7 months
To register the footprints of the rats, strips of paper measuring 43 cm long by 8.7 wide, sizes that are considered as being adequate for the rats ‘catwalk’ and built as per the De MEDINACELI; FREED; WYATT (1982) drawing. The paper was previously soaked in a solution of bromophenol blue were used.
For the preparation of the paper the bromophenol blue in its anhydrous (Sigma) form was diluted in at 1% in absolute acetone, acquiring an orange color.
The sheets of paper were soaked in this solution and placed in the sun to dry, then they were cut into strips and stored in plastic packages, so as to avoid humidity, which could alter the blue color.
The animals were made to walk on the catwalk covered with the previously prepared paper strips, with their hind legs soaked in a solution of neutral detergent, which immediately changes the color of the footprint from yellow to blue . The footprints remain on the paper strips, which were left to dry for the reading of the necessary measures to calculate the Sciatic Functional Index .
Later these were analyzed by a computer program (software) developed by SELLI (1998) , to obtain the Sciatic Functional Index that was proposed by BAIN; MACKINNON; HUNTER (1989), which takes into account the print length, the total toe spread between the 1st to the 4th toe, and the intermediate toes which are the 2nd and 3rd. The footprints of each animal were obtained before the application of Myomodulation, as a control, and immediately after the Myomodulation injection, and again, and at periodic intervals, when the animals were sacrificed for the extraction of the anterior tibia muscle for histological study.
The footprints were digitalized with a scanner and placed into the SELLI program, which allows for the capture, identification and analysis of the images, allowing for the application of other methods of identification of the Sciatic Functional Index (DE MEDINACELI, FREED & WYATT, 1982; DE MEDINACELI, DERENZO & WYATT, 1984; CARLTON & GOLDBERG, 1986), as well as Tibia Functionality indexes and the peroneal nerve (BAIN; MACKINNON & HUNTER, 1989). Once the footprint is shown on the monitor, its parameters are analyzed and measured, which require the placing of the cursor to be clicked in the correct predetermined sequence. The program then calculates and supplies the value of the index, and this is also stored in the computer.
Footprints of the mouse after 0.05 ml injection in the right pre tibial muscle
Schematic representation of the measurements realized to calculate the Sciatic Functional Index.
E: Experimental (operated foot);
N: Normal (opposite foot);
TS: Total opening of the toes (1st to 5th);
IT: Opening of the intermediate toes (2nd to 4th);
PL: Length of footstep
NaCl 0.9%, 0.1 ml into the pretibial muscle does not alter the gait.
The alteration in the gait caused by Myomodulation decreases with time when applied via intramuscular, at this level of concentration.
The molecular biology framework presented on this page reflects the conceptual and scientific work developed by Mauro Tiziani .
His approach integrates bioenergetics, molecular structure, and non-equilibrium biological systems to describe tissue modulation beyond injury-repair models.
This conceptual foundation serves as the scientific backbone for the Myomodulation methodology, later translated into clinical protocols and reproducible outcomes.
Myomodulation is based on a bioregenerative biological model that focuses on restoring intracellular energetic organization rather than inducing tissue injury. Its primary effect is the reduction of oxidative interference affecting DNA-associated macromolecules, allowing intrinsic cellular control mechanisms to resume normal function.
Myomodulation acts at the molecular and energetic level of the cell, where oxidative stress disrupts regulatory macromolecular structures involved in gene expression and signal control.
By reducing oxidative interference, cellular regulatory pathways regain coherence, leading to improved metabolic coordination without triggering inflammatory repair cascades.
The molecular design of Myomodulation is based on a low molecular weight aromatic structure, selected for optimal cellular accessibility and bioenergetic compatibility.
Low molecular weight enables rapid tissue diffusion and direct cellular access without prior enzymatic degradation.
The molecule can penetrate the cell through ionic channels and membrane-associated pathways, avoiding metabolic overload.
Minimal molecular complexity enhances the cell’s ability to recognize and utilize the signal efficiently.
A defining characteristic of the aromatic structure used in Myomodulation is the relative instability of its hydroxyl-associated hydrogen, conferring a controlled bioenergetic reactivity.
The unstable hydrogen represents an energetically active site capable of participating in intracellular energy-transfer processes.
This reactivity occurs without structural damage, allowing modulation rather than destruction of molecular systems.
Myomodulation’s biological activity involves a bioenergetic interaction at the plasma membrane level, driven by transmembrane electrical potentials.
Transmembrane potentials transport electrons across the plasma membrane during normal cellular activity.
These electrons interact with the aromatic structure, preferentially targeting the unstable hydrogen.
The hydrogen is converted into a proton (H⁺), representing a localized and efficient energetic transformation.
The generated protons migrate toward the intracellular environment, where they interact with macromolecular assemblies involved in signaling and metabolic regulation.
Proton interaction modifies the conformational state of proteins and signaling complexes, improving their functional alignment.
These interactions contribute to the hydrolysis and neutralization of oxidative factors that impair molecular communication.
From a molecular biology perspective, tissue aging is associated with increasing biological entropy and loss of metabolic directionality.
Energy dispersion and inefficient coupling between energy and biological work characterize aged tissues.
Myomodulation reduces local entropy by simplifying energetic inputs rather than increasing molecular complexity.
improved energetic order enhances cellular responsiveness and metabolic coherence.
Highly complex or large molecular systems impose significant energetic costs on biological tissues.
Such systems require fragmentation, dissipate energy as heat, and generate non-functional intermediates.
Myomodulation relies on bioenergetically efficient, low-complexity molecules to minimize metabolic waste.
Myomodulation does not depend on tissue injury followed by reparative inflammation. Its objective is energetic and metabolic reorganization.
Restoration of intracellular fluxes and functional gradients without inducing damage.
Effective even in aged or metabolically compromised tissues.
Results are reproducible, coherent, and based on metabolic optimization rather than injury-repair cycles.
Myomodulation represents a bioenergetically coherent approach to tissue modulation, where therapeutic efficacy is achieved by restoring metabolic order rather than increasing molecular complexity.
Myomodulation is not defined by a single mechanism, but by a coherent bioenergetic framework.
By reducing molecular complexity and restoring metabolic order, it enables biological responses without relying on injury-based repair models.
This conceptual foundation underlies all clinical applications of the Myomodulation methodology.